Argos Therapeutics Publishes Positive Immune Response, Safety And Manufacturing Data For Its Arcelis™ HIV Program In Clinical Immunology
Argos Therapeutics announced the publication of a manuscript in the February edition of Clinical Immunology, detailing positive immune response, safety and manufacturing data for its AGS-004 immunotherapy for HIV...
Rate this article



del.icio.us
Digg
Comments (0 posted):
Post your comment